2024 Update on the Treatment of Pituitary Tumors


2024 Update on the Treatment of Pituitary Tumors Banner

Add to Calendar 2024 Update on the Treatment of Pituitary Tumors 4/5/2024 9:00:00 AM 4/5/2024 4:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=42751 Description: This didactic and case-based program will update attendees on the latest developments in ongoing basic and translational science and the clinical management of patients with pituitary conditions. This course aims to improve patient care and outcomes through evidence-based discussion of clinical practice guidelines and emerging therapies. Our goal is to assess and update current practices to promote ear... Online false MM/DD/YYYY


Date & Location
Friday, April 5, 2024, 9:00 AM - 4:00 PM, Online

Specialties
Specialties - Endocrinology, Diabetes and Metabolism, ENT, Head and Neck Oncology, Head and Neck Surgery, Integrative Medicine, Internal Medicine, Molecular Pathology, Neuro-Oncology, Neuropathology, Neuroradiology, Neurosurgery, Nursing, Otolaryngology, Patient or Caregiver

Overview

This didactic and case-based program will update attendees on the latest developments in ongoing basic and translational science and the clinical management of patients with pituitary conditions. This course aims to improve patient care and outcomes through evidence-based discussion of clinical practice guidelines and emerging therapies. Our goal is to assess and update current practices to promote earlier diagnosis and treatment of pituitary diseases. The multidisciplinary nature of the course will allow for the dissemination of knowledge across the variety of practitioners caring for patients with pituitary diseases and for the patients themselves.

Afternoon Breakout Tracks

The afternoon will comprise of two separate interactive tracks - a clinical track for providers and a separate track geared towards patients and caregivers. 

Provider/Clinical Track: Request for Case Submissions

During the provider/clinical track, there will be an interactive tumor board providing attendees and faculty an opportunity to review cases. We invite the submission of cases for discussion during this session. Submission should be made at registration. In order to prepare your submission, we ask that you provide a BRIEF summary of your case and include key lab results. Please ensure that all identifiable PHI has been removed. Cases should have an educational purpose. The course faculty will not be able to provide a detailed/complex consult review during the course and will try to get through as many cases as possible.

Patient/Caregiver Track

Patients with pituitary disease and their caregivers are invited to attend this educational activity on a complimentary basis and participate in this interactive track. Pituitary patients can review treatment options, learn about ongoing clinical trials, and discuss their comprehensive care with providers and other patients. The educational objective of this patient session is to provide a forum for pituitary patients to discuss treatment options and new therapies with providers and other patients. Please note AMA PRA Category 1 Credits™ will not be offered for the patient breakout session.

The registration fee is waived for patients and caregivers to attend this course. If you are interested in attending this program, we ask that you email [email protected]. 

Overall this course aims to improve patient care and outcomes through evidence-based discussion of clinical practice guidelines and emerging therapies in order to assess and update current practices to promote earlier diagnosis and treatment of pituitary diseases.

This educational activity is presented by the Memorial Sloan Kettering Multidisciplinary Pituitary & Skull Base Tumor Center and endorsed by the Cushing’s Support & Research Foundation (CSRF) and Acromegaly Community.

Who Should Attend

This course is intended for endocrinologists, neurosurgeons, otolaryngologists, radiation oncologists, neurologists, ophthalmologists, neuro-oncologists, family medicine and internal medicine physicians, physicians in training, and other allied health professionals who treat and manage patients with pituitary diseases. We also invite patients with pituitary disease and their caregivers to attend this educational activity and participate in our interactive afternoon breakout sessions.

Please note this program will be held virtually via Zoom. Detailed access instructions will be emailed to attendees prior to the start of the event.

Online Syllabus

Attendees will receive access to a syllabus after the program concludes, which will include select PDFs of the faculty presentations (slides) and video clips. Attendees must check in during the live program in order to receive access to the syllabus.

Objectives
  1. Review available and emerging medical therapies for Cushing’s and acromegaly
  2. Explain decision making involved in surgical interventions for pituitary tumors
  3. Discuss the use of patient reported outcomes for pituitary patients
  4. Present recent data on mechanisms for the development of treatment resistant and malignant pituitary tumors
  5. Debate treatment decisions supporting the use and timing of new therapies for treatment resistant and malignant pituitary tumors

Registration

Registration Fees

  • Physicians (MDs, PhDs, and DOs): $175
  • Residents, Fellows, Advanced Practice Providers, Nurses, and Other Healthcare Providers: $125
  • Industry Professionals*: $300
  • Patients and Caregivers: Complimentary - Please complete registration through the patient/caregiver form.
  • MSK Employees: Complimentary - Please sign in to the MSK CME Portal using your MSK login credentials (SSO)

A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this program. If you are a member of one of these groups, please submit your request here for this discount. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 5.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
  • 5.50 Annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABOHNS MOC/CC credit.

ANCC CNE Statement

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

5.50 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.